Statistics

Total Visits

Views
Comparative study of infliximab versus adalimumab in patients with refractory uveitis due to behcet's disease multicenter study of 125 cases71

Select a period of time:

Number of views in the range

Views
Comparative study of infliximab versus adalimumab in patients with refractory uveitis due to behcet's disease multicenter study of 125 cases40

Views

Views
April 20252
May 20250
June 20250
July 202530
August 20251
September 20251
October 20256
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States12
Brazil11
Hong Kong8
United Kingdom2
Ecuador1
Spain1
Ethiopia1
Kenya1
Mexico1
Turkey1
 

Top cities views

Views
Hong Kong8
São Paulo2
Addis Ababa1
Aparecida de Goiânia1
Campinas1
Chicago1
Concord1
Council Bluffs1
Covington1
Dallas1